IL-33 has shown a protective role in the ApoE−/− experimental atherosclerosis mice model, increasing serum levels of Th2-type cytokines, and enriching ST2+CD4+ T cells in lymph nodes (26). The gene discussed is IL1RL1; the disease is atherosclerosis.